HP and type 2 diabetes mellitus: A group of studies was previously launched to explore the causality underlying the relationship of several novel biomarkers with macroangiopathy risk [9–11], and a causal relationship between serum haptoglobin (Hp) levels and macroangiopathy was observed in Chinese T2DM patients via Mendelian randomization analysis [12].